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Efficient Molecular Genetic Diagnosis
of Enlarged Vestibular Aqueducts in East Asians
Byung Yoon Choi,1,2 Andrew K. Stewart,3 Katherine K. Nishimura,3 Won Jae Cha,1 Moon-Woo Seong,4
Sung Sup Park,4 Seung Won Kim,5 Yang Sook Chun,5,* Jong Woo Chung,6 Shi-Nae Park,7 Sun O. Chang,1
Chong-Sun Kim,1,{ Seth L. Alper,3 Andrew J. Griffith,8 and Seung-Ha Oh1,9
Context: Enlargement of the vestibular aqueduct (EVA) is a commonly detected inner ear anomaly related to
hearing loss and often associated with mutations of SLC26A4 encoding pendrin, a transmembrane exchanger of
Cl, I, and HCO3
. Here we describe the phenotypes of 27 Korean EVA subjects and their SLC26A4 genotypes
determined by bidirectional nucleotide sequencing. Results: The detected variants include two novel missense
substitutions (p.V138L and p.P542R). We characterized the ability of p.V138L and p.P542R pendrin products to
traffic to the plasma membrane in COS-7 cells and to transport Cl, I, and HCO3
 in Xenopus oocytes. The
results indicate that p.P542R is a benign polymorphic variant, whereas p.V138L is a pathogenic mutation. Since
this and other studies of East Asian EVA cohorts show that the majority of SLC26A4 mutations affect either or
both of two amplicons (exons 7–8 and 19), we developed a hierarchical protocol that integrates direct se-
quencing with denaturing high-performance liquid chromatography analyses for detection of SLC26A4 muta-
tions in these populations. We validated the cost efficiency of the integrated protocol by a simulated screen of
published East Asian EVA cohorts with known SLC26A4 genotypes. Conclusions: Our study further defines the
spectrum of SLC26A4 mutations among East Asians and demonstrates a rapid and efficient protocol for their
detection.
Introduction
Enlargement of the vestibular aqueduct (EVA; MIM600709) is a common radiological inner ear malformation
associated with sensorineural hearing loss (Valvassori and
Clemis, 1978). EVA is the radiologic finding of highest pene-
trance in the syndrome of recessive sensorineural hearing loss
with goiter (Pendred syndrome [PDS]; MIM 274600) but can
also be observed without goiter in nonsyndromic EVA
(NSEVA) (DFNB4; MIM 600791) (Phelps et al., 1998). Muta-
tions of SLC26A4, which encodes pendrin, can cause either
PDS or NSEVA (Everett et al., 1997; Li et al., 1998; Usami et al.,
1999). Pendrin, a polytopic transmembrane protein, ex-
changes Cl and I across the apical membrane of thyroid
follicular cells (Royaux et al., 2000; Gillam et al., 2004). It is also
expressed in the inner ear, where it has been proposed to
exchange Cl and HCO3
 (Wangemann et al., 2007). Pendrin
is also expressed in type B intercalated cells of the renal col-
lecting duct (Royaux et al., 2001), and in respiratory and
mammary epithelial cells (Rillema and Hill, 2003; Pedemonte
et al., 2007), although its absence in these tissues is not known
to contribute to the phenotype of PDS.
The overlap of SLC26A4 genotypes and phenotypes in PDS
and NSEVA has led to uncertainty in their nosology. This
uncertainty is compounded by the detection of only one re-
cessive mutant allele of SLC26A4 in many EVA patients and
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by the uncertain pathogenic potential of many SLC26A4
variants (Choi et al., 2009). Many of these variants are mis-
sense substitutions whose pathogenic potential may be clari-
fied by evaluation of their genotypic and phenotypic context
in the EVA patient as well as by functional characterization of
their intracellular trafficking and anion exchange properties
(Choi et al., 2009).
The expense of bidirectional DNA sequencing of all 21 ex-
ons of SLC26A4 and their adjacent splice sites is an obstacle to
widespread molecular diagnostic testing of EVA patients.
Alternative methods include denaturing high-performance
liquid chromatography (DHPLC) (Prasad et al., 2004; Albert
et al., 2006) and exon-specific strategies (Park et al., 2003). The
latter can be incorporated into hierarchical screens that ac-
count for different identities and distributions of mutations of
SLC26A4 among different ethnic populations (Tsukamoto
et al., 2003; Park et al., 2005; Pryor et al., 2005; Wu et al., 2005b;
Albert et al., 2006; Wang et al., 2007). This type of strategy has
been proposed for the comparatively restricted distribution of
SLC26A4 mutations prevalent in East Asian EVA subjects
(Park et al., 2005; Wu et al., 2005b; Dai et al., 2008; Guo et al.,
2008).
The purpose of this study was to refine the known SLC26A4
mutation spectrum in Korean EVA patients and to develop a
DHPLC screen to detect these mutations. We show that a
DHPLC screen can be integrated with direct nucleotide se-
quencing into a cost-effective hierarchical protocol for the
detection of SLC26A4 mutations in Korean EVA patients. We
validate the protocol by a simulated analysis of published
EVA cohorts with known SLC26A4 genotypes from a variety
of East Asian populations. We also demonstrate an evaluation
of pathogenicity of two interesting novel missense substitu-
tions, one of which is the second most frequent missense
variant from our Korean cohort in this study.
Materials and Methods
Subjects
This study was approved by the institutional review board
of the Seoul National University Hospital (IRB00002177 and
FWA00008721). Written informed consent was obtained
from the subjects or their parents. Twenty-seven unrelated
subjects (probands) had a computed tomography scan
showing a vestibular aqueduct diameter greater than 1.5 mm
at the midpoint between the common crus and the external
aperture. All subjects had bilateral severe to profound
hearing loss (70 dB HL in the better-hearing ear) by serial
audiological examinations, including pure tone audiometry,
auditory brainstem response analysis, or both. Subjects
with syndromic features other than goiter were excluded. Of
the 27 subjects, 11 had a family history of hearing loss with
EVA, whereas the other 16 subjects were sporadic cases.
Fifty normal Koreans were control subjects for genotype
analyses.
SLC26A4 genotype analysis
Genomic DNA was isolated from peripheral blood leuko-
cytes using Gentra PureGene (Qiagen, Valencia, CA). All 21
exons and adjacent intronic sequences of SLC26A4 were am-
plified by polymerase chain reaction (PCR) and sequenced as
described (Park et al., 2003). DNA from parents and siblings,
when available, was evaluated to determine segregation and
meiotic phase configuration of mutant alleles of SLC26A4 in
probands with two mutations.
Functional analysis of novel missense variants
We expressed wild-type or variant pendrin (p.V138L and
p.P542R), fused at its C-terminus to enhanced green fluores-
cent protein, in COS-7 cells and evaluated its trafficking as
described (Choi et al., 2009). Wild-type and variant pendrin
products were expressed in Xenopus oocytes for measurement
of Cl=I and Cl=HCO3
 exchange activity as described
(Stewart et al., 2004, 2007; Choi et al., 2009).
DHPLC
DHPLC primers and amplicon lengths were selected as
described (Prasad et al., 2004). We also designed a new primer
pair for amplicon 7–8: 50-GTG GGA AGA TTC ATA TGA
GAA TTG (forward) and 50-GTT TCT TCC AGA TCA CAC
ACA A (reverse). PCR amplifications were performed in 50mL
containing 100 mM dNTPs, 100 ng template DNA, 10 pmol of
each primer, and 1.25 U Ace-Taq DNA Polymerase (Gen-
enmed, Seoul, Korea) in 1reaction buffer (30 mM Tris-HCl,
pH 9.1; 50 mM KCl; 2 mM MgCl2). The amplifications were
performed using a PTC-100 Thermal Cycler (Bio-Rad, Her-
cules, CA) with an initial denaturation of 5 min at 958C fol-
lowed by 30-step cycles (10 s at 948C, 20 s at 578C, and 30 s at
728C) and a final extension for 10 min at 728C.
DHPLC was performed using the Wave System (Transge-
nomic, Omaha, NE). PCR products were mixed with
sequence-confirmed wild-type products at a 2:1 ratio to detect
homozygous mutations. The mixture was denatured at 958C
for 5 min followed by a reduction in temperature from 958C to
258C over 45 min (Prasad et al., 2004). Five microliters of each
mixture was loaded onto a DNASep-HT column (Transge-
nomic), and amplicons were eluted in 0.1 M triethylammo-
nium acetate, pH 7, using a linear acetonitrile gradient at a
flow rate of 1.5 mL=min. Heteroduplex mismatches were de-
tected by the appearance of extra peaks or a distortion of
peak shape. Temperatures were calculated using Navigator
Software (Transgenomic) and a Web site tool at http:==
insertion.stanford.edu=melt.html. Amplicons for exons 14, 16,
18, and 21 required one DHPLC temperature, whereas all
other amplicons required two assays at two different tem-
peratures (Table 1).
Simulated mutation screening
To compare the cost of different screening strategies, we
assembled a composite cohort of 247 EVA subjects with
known SLC26A4 genotypes from seven independent studies.
The cohort included 58 Koreans from this and two other
studies (Park et al., 2005; Lee et al., 2008), 42 Japanese (Tsu-
kamoto et al., 2003), and 147 Chinese (mainland Chineseþ
Han Chinese) (Wu et al., 2005b; Hu et al., 2007; Wang et al.,
2007). Owing to the possibility of overlap of some EVA sub-
jects between two reported Japanese cohorts (Tsukamoto et al.,
2003; Suzuki et al., 2007), we included only one study with a
larger cohort in our composite cohort (Tsukamoto et al., 2003).
The estimated reagent cost per amplicon for sequencing and
DHPLC screening at a single temperature was US$11.00 and
US$1.60, respectively.
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Results
SLC26A4 genotypes
The SLC26A4 genotypes of our Korean EVA subjects
are shown in Table 2. Sixteen (59.3%) of 27 subjects had two
likely pathogenic variants, 7 (25.9%) had one variant, while 4
(14.8%) had no detectable pathogenic variants. p.H723R and
c.919-2A>G constituted 30 (76.9%) of 39 potentially patho-
genic alleles. Eight (50%) of 16 subjects carrying two SLC26A4
variants were homozygous for either of these two prevalent
founder mutations (Park et al., 2003; Wu et al., 2005b).
Novel missense variants
We detected two novel missense variants, p.V138L
(c.412G>C) and p.P542R (c.1625C>G), that segregated with
deafness within each family. p.V138L was the second most
frequent missense variant in this study (Table 2). p.P542R
was detected in a sporadic EVA case (subject 7), and the
subject had more severe inner ear anomalies in addition to
atypical EVA (Fig. 1). These residues are conserved in hu-
man, rat, and mouse SLC26A4 orthologs. Neither variant
was detected in 100 normal Korean control chromosomes.
The p.V138L pendrin product displayed an intracellular
Table 1. Denaturing High-Performance Liquid
Chromatography Amplicons and Temperatures
Exon Size (bp) DHPLC temperature (8C)
1 403 61.7, 65.2
2 292 64.0, 68.0
3 242 59.2, 60.9
4 243 54.9, 60.5
5 373 53.6, 59.5
6 288 55.0, 60.0
7–8 576 54.7, 56.7
9 254 57.5, 59.0
10 288 58.2, 64.7
11–12 485 56.1, 59.6
13 264 53.0, 61.9
14 387 56.7
15 254 55.0, 56.0
16 241 56.2
17 374 55.7, 59.0
18 190 56.1
19 312 55.3, 57.7
20 246 53.3, 56.8
21 296 59.0
DHPLC, denaturing high-performance liquid chromatography.
Table 2. SLC26A4 Phenotypes and Genotypes of Korean Subjects
with Enlargement of the Vestibular Aqueduct
Hearing (dB)a SLC26A4 genotype
Subject Sex Age (yearmonth) Right Left Allele 1 Allele 2
1 F 12 100 100 p.H723R Wild type
2 F 17 110 70 Wild type Wild type
3 M 9 110 110 p.H723R p.M147V
4 F 12 110 110 p.H723R p.V138L
5 M 16 110 110 p.H723R c.919-2A>G
6 M 11 100 100 p.H723R p.L676Q
7 M 8 100 100 p.P542R Wild type
8 M 12 110 90 p.H723R c.919-2A>G
9 F 4 NR NR p.H723R p.H723R
10 M 21 110 110 p.H723R Wild type
11 M 24=12 NR NR p.H723R p.H723R
12 M 110=12 NR NR c.919-2A>G p.V659L
13 F 7 85 85 c.919-2A>G c.919-2A>G
14 F 12 NR NR p.H723R p.H723R
15 M 7 NR NR p.H723R p.H723R
16 F 8 NR NR p.H723R p.H723R
17 F 3 75 85 p.H723R p.H723R
18 M 24=12 NR NR p.H723Rb p.V138Lb
c.165-13T>Gb
19 M 2 NR NR p.H723R p.H723R
20 M 12=12 NR NR Wild type Wild type
21 M 34 100 100 Wild type Wild type
22 F 8 90 90 p.H723R Wild type
23 F 2 NR NR c.919-2A>G Wild type
24 M 3 100 100 Wild type Wild type
25 F 12 70 70 c.1707þ 5G>A Wild type
26 M 21 NR NR p.H723R Wild type
27 M 27 100 100 p.V138L c.1149þ3A>G
c.1341þ 47T>C (rs17154326) were detected in subjects 7 and 21. In subject 7, c.1341þ 47T>C was in trans with p.P542R.
Novel variants are in bold.
aPure tone averages (dB HL) at 500 Hz, 1 kHz, and 2 kHz or auditory brainstem response threshold.
bMeiotic configuration could not be determined.
NR, no response.
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reticular pattern with no detectable localization at the plas-
ma membrane in COS-7 cells, whereas the wild-type and
p.P542R products colocalized with concanavalin A at the cell
surface (Fig. 2a). The p.V138L pendrin rate constants for
Cl=Cl, Cl=I, and Cl=HCO3
 exchange, respectively,
were 26–30%, 42%, and 22% of those for wild-type pendrin.
The p.P542R pendrin product exhibited respective rate con-
stants that were 61–100%, 74%, and 95% of the correspond-
ing wild-type rate constants, respectively (Fig. 2c, e).
Novel splice site variant
The c.165-13T>G intronic variant in subject 18 may be
pathogenic because this variant was not detected in 100
normal Korean control chromosomes, and it is located in a
highly conserved region among human, rat, mouse, dog,
and chicken. Two different programs (http:==rulai.cshl.edu=
cgi-in=tools=ESE3=esefinder.cgi?process¼home and www
.fruitfly.org) predict that this nucleotide change creates a
cryptic splice acceptor site whose utilization would disrupt
the open reading frame. Samples from family members were
unavailable to determine if c.165-13T>G is in cis configuration
with either of two other mutations, p.V138L or p.H723R, in
subject 18.
DHPLC detection of Korean variants of SLC26A4
To evaluate the sensitivity and specificity of DHPLC for
detecting SLC26A4 variants in our EVA cohort, we analyzed
513 amplicons (27 EVA subjects vs. 19 amplicons). Forty-two
amplicons showed an aberrant elution profile (EP), yielding a
detection rate of 1.55 (42=27) abnormal EPs per subject. Thirty-
four (81%) of 42 aberrant EPs represented true nucleotide
variations. These 34 EPs included two from amplicons with a
known single-nucleotide polymorphism (SNP), c.1341þ
47T>C (rs17154326). All of the variants among the 27 subjects
could be identified by abnormal EP, yielding a sensitivity of
100% for DHPLC (Fig. 3a). All of the eight false-positive EPs
were for wild-type amplicon 7–8 amplified with primers
originally reported by Prasad et al. (2004) (data not shown).
Therefore, we designed a new primer pair for amplicon 7–8
that produces distinguishable EP for the wild-type allele and
c.919-2A>G homozygotes (Fig. 3b).
SLC26A4 mutation distribution
The exonic distribution of SLC26A4 mutations among
East Asian EVA subjects from this and seven other studies
is shown (Fig. 4). Japanese cohorts showed a similar
spectrum with that from our Korean cohort (Tsukamoto
et al., 2003; Suzuki et al., 2007). Although Han Chinese
population showed a distinctive mutation spectrum where
c.919-2A>G alone accounted for most of the mutant alleles
of SLC26A4 (Wu et al., 2005b), two largest studies with
mainland Chinese population (Wang et al., 2007; Guo et al.,
2008) indicated that p.H723R is the second most frequent
mutation following c.919-2A>G. Resultantly, 319 (73%) of
532 East Asian EVA mutations are located in DHPLC
amplicons 7–8 and 19. Among these eight studies, indi-
vidual SLC26A4 genotypes were available for 247 subjects
from this and six independent studies. Ninety-seven (39%)
of 247 subjects had two mutations located in either or both
of these amplicons. This was true for 36%, 31%, and 43% of
Korean, Japanese, and Chinese (mainland ChineseþHan
Chinese) subjects, respectively.
FIG. 1. Temporal bone com-
puted tomography scans. A
coronal section of subject 7
(p.P542R=þ) shows an en-
larged vestibule (black ar-
rowhead) and absent superior
semicircular canal. An axial
section demonstrates severe
cochlear hypoplasia (black ar-
row) and poor mastoid pneu-
matization (white circle) in
addition to enlargement of the
vestibular aqueduct (EVA)
(white arrow). Examination of
adjacent sections confirmed
this latter structure as the
vestibular aqueduct and not
the jugular bulb. Another
subject (p.H723R=þ) with a
typical EVA has a superior
semicircular canal (black dot-
ted arrow), relatively normal
cochlea, a well-pneumatized
and aerated mastoid, and
EVA (white arrow).
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Integrated DHPLC sequencing protocol
We designed an integrated protocol for East Asian
SLC26A4 mutation detection in which the first step is bidi-
rectional sequencing of two amplicons (exons 7–8 and 19). If
this does not reveal two pathogenic alleles, the other 17 am-
plicons are screened by DHPLC and directly sequenced if
they show abnormal EPs (Fig. 5). We sought to compare
the estimated costs of this integrated protocol with those of
nonhierarchical direct sequencing or DHPLC analyses of all
amplicons. We calculated the estimated costs for each of
these strategies in simulated screens based upon published
FIG. 2. (a) Intracellular trafficking of pendrin variants in COS-7 cells. Merged representative images show green fluorescent
protein–tagged wild-type or missense allele products (green) and concanavalin A staining (red) of plasma membrane.
Colocalization (yellow) demonstrates targeting of pendrin to the plasma membrane. Scale bars¼ 20 mm. (b) Time course of
36Cl efflux from representative oocytes and (c) rate constants (mean SE) for each group of (n) oocytes expressing wild-type
or variant pendrin in extracellular medium containing 96 mM Cl, 0 Cl=5 mM I, or 0 Cl=0 I, with gluconate as equimolar
substituent anion. (d) Time course of 36Cl efflux from representative oocytes and (e) rate constants (mean SE) for each group
of (n) oocytes expressing wild-type or variant pendrin in extracellular medium containing 96 mM Cl, 72 mM Cl=24 mM
HCO3
, or 0 Cl=24 mM HCO3
=72 mM gluconate. Color images available online at www.liebertonline.com=gtmb.
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genotype results for a composite cohort of 247 East Asian EVA
subjects from this and six other studies. The costs per subject
for the integrated, nonhierarchical DHPLC, and sequencing
protocols were $56.00, $69.36, and $209.00, respectively. Our
integrated protocol is predicted to reduce the overall cost by




The missense substitution c.412G>C (p.V138L) affects the
same amino acid as the well-characterized pathogenic muta-
tion c.412G>T (p.V138F) (Van Hauwe et al., 1998; Borck et al.,
2003). The three subjects with p.V138L all had at least one
other pathogenic variant. We confirmed trans configuration of
p.V138L with the other mutations in two subjects, but family
members were not available to determine meiotic configura-
tion in the third subject (subject 18) (Table 2). The retention of
p.V138L pendrin in the cytoplasm, most likely endoplasmic
reticulum, of COS-7 cells (Fig. 2a), as previously described for
other pathogenic SLC26A4 variants including missense vari-
ants that were also detected in this Korean cohort (p.H723R,
p.M147V, and p.L676Q) (Table 2) (Rotman-Pikielny et al.,
2002; Taylor et al., 2002; Yoon et al., 2008), confirms its path-
ogenic potential. Nearly no residual hearing in these subjects
4, 18, and 27 (Table 2) is compatible with this abnormal traf-
ficking. However, interestingly, p.V138L retains some resid-
ual exchange activity in nonmammalian Xenopus oocytes (Fig.
2b–e). This contrasts with the complete loss of iodide efflux
activity previously described for p.V138F pendrin expressed
in mammalian cells (Taylor et al., 2002). This difference may
arise from differences in expression temperature, choice of
heterologous expression system (Karniski, 2001, 2004), or in-
trinsic properties of the mutant residue side chains. Since this
substantial residual exchange activity of p.V138L is also in
contrast with almost complete loss of functions recorded from
p.L236P, p.E384G, and p.T416P in an identical expression
system at the same temperature (Choi et al., 2009), p.V138L
might resemble p.H723R in its potential susceptibility to
therapeutic strategies to facilitate plasmalemmal trafficking of
potentially functional pendrin from the endoplasmic reticu-
lum (Kim and Arvan, 1998; Gillam et al., 2004; Yoon et al.,
2008).
The intracellular trafficking and anion exchange properties
of p.P542R pendrin suggest that it is a fortuitously detected
benign polymorphic variant, although this rare variant is
conserved in human, rat, and mouse SLC26A4 orthologs and
was not detected in 100 normal Korean control chromosomes.
In this study, this conclusion is supported by the genotypic
and phenotypic context in which it was detected (Taylor et al.,
2002; Pfarr et al., 2006; Choi et al., 2009). It was detected once as
a single heterozygote (subject 7) (Table 2) in a subject with
EVA accompanied by superior semicircular canal agenesis,
severe cochlear hypoplasia, and severe hypopneumatization
of the mastoid (Fig. 1). This constellation of severe anomalies
probably reflects an etiology other than SLC26A4 mutations in
this subject (subject 7) (Wu et al., 2005a; Fitoz et al., 2007).
However, a pathogenic contribution of p.P542R pendrin to
EVA via a complex or oligogenic mechanism in this patient
cannot be completely ruled out. In contrast, the single mutant
alleles with known or probable pathogenicity in subjects 1, 10,
22, 23, 25, and 26 (Table 2) (Park et al., 2005; Wu et al., 2005b;
Yoon et al., 2008) are highly likely to contribute to the patho-
genesis of EVA as supported by much more frequent detec-
tion of single mutations of SLC26A4 in nonsyndromic EVA
patients than in normal Western controls (Campbell et al.,
FIG. 3. (a) Electropherograms and denaturing high-
performance liquid chromatography (DHPLC) elution
profiles (EP) for novel SLC26A4 sequence variants (red
arrowheads). (b, c) DHPLC EP of normal control, heterozy-
gous, or homozygous c.919-2A>G (b) or p.H723R (c) vari-
ants with or without sequence-verified wild-type DNA
added at a ratio of 2:1. EP differences for homozygotes are
less prominent than for heterozygotes.
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FIG. 4. Exonic distribution
of SLC26A4 mutations in East
Asian EVA subjects from this
and seven other studies (Tsu-
kamoto et al., 2003; Park et al.,
2005; Wu et al., 2005b; Hu et al.,
2007; Wang et al., 2007; Guo
et al., 2008; Lee et al., 2008) and
Caucasian (western) EVA
subjects from four studies
(Prasad et al., 2004; Pryor et al.,
2005; Albert et al., 2006; Pera
et al., 2008).




DHPLC, and (c) nonhierar-
chical DHPLC simulated
screens of a composite cohort
of 247 East Asian EVA sub-
jects from this and six other
studies (Tsukamoto et al.,
2003; Park et al., 2005; Wu
et al., 2005b; Hu et al., 2007;
Wang et al., 2007; Lee et al.,
2008). Numbers of subjects are
in circles. Asterisks indicate
numbers of DHPLC analysis
temperatures.
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2001; Park et al., 2003; Pryor et al., 2005; Albert et al., 2006;
Azaiez et al., 2007; Pera et al., 2008).
Integrated DHPLC sequencing protocol
A definitive molecular diagnosis could be made with the
first step of this integrated protocol for approximately 40% of
East Asian EVA subjects. DHPLC analyses detect not only
pathogenic variants but also nonpathogenic variants or SNPs.
Most of the missense variants detected in East Asians to date
have proven to be pathogenic (Yoon et al., 2008), and we also
show that p.V138L, a second most frequent missense variant
in this study, is clearly pathogenic. However, because of lack
of information about the frequency of SNP detection in the
other East Asian subjects in our composite cohort, our simu-
lation could not count for those unreported possible SNPs.
Our Korean cohort showed only one known SNP twice in
addition to one splice site (c.165-13T>G) and one missense
(p.P542R) variants of unknown pathogenicity among 513
amplicons (Table 2), indicating that SNPs are not frequent in
SLC26A4 in Korean EVA subjects. If SNPs to be confirmed by
the sequencing are not rare in the other East Asian cohorts
unlike in our Korean cohort, then cost effectiveness of DHPLC
screening compared with a sequencing protocol might not be
as high as predicted in our simulation. Even in this situation,
our integrated protocol will have a substantial advantage in
the cost reduction over the nonhierarchical DHPLC screening
because a molecular diagnosis of about 40% of East Asian
EVA subjects does not require further DHPLC screening in
our integrated protocol.
Another advantage of our hierarchical integrated protocol
is that it circumvents DHPLC screening of all, or nearly all,
homozygous variants that are common potential sources of
false-positives or false-negatives in this population. Although
our conditions and primers permit the detection of homozy-
gous mutations, EP differences for homozygotes are less
prominent than for heterozygotes (Fig. 3b, c).
Better cost effectiveness can be achieved by substituting
PCR-based allele-specific detection methods (Dai et al., 2008)
or direct sequencing of only one amplicon for the first step of
our integrated protocol, direct sequencing of both exons 7–8
and 19, in some geographic regions, such as Taiwan, with
distinct features in exonic distribution of SLC26A4 mutations
(Wu et al., 2005b).
This type of hierarchical protocol will be most useful in
populations with one or a few prevalent mutations with a
proven pathogenicity and a high proportion of EVA patients
with two mutant alleles of SLC26A4. The protocol’s advan-
tages are unlikely to be as significant in European and other
mixed populations characterized by broader mutation dis-
tributions and fewer EVA patients with two mutant alleles
(Fig. 4) (Prasad et al., 2004; Pryor et al., 2005; Albert et al., 2006;
Pera et al., 2008; Choi et al., 2009). Future studies to define the
identities and distributions of SLC26A4 mutations among
different ethnic populations are justified by their compara-
tively high prevalence as a cause of deafness (Park et al., 2003;
Dai et al., 2008; Guo et al., 2008).
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